Capitol Observations - Written by Jere Beasley on Monday, August 11, 2008 13:08 - 1 Comment
Connecticut Sues Eli Lilly Over Zyprexa Marketing
The State of Connecticut has filed suit against Eli Lilly and Co. alleging that the drug maker illegally marketed and concealed serious side effects of Zyprexa, its top-selling schizophrenia medicine. Connecticut Attorney General Richard Blumenthal is seeking to recover “millions of taxpayer and consumer dollars improperly spent on Zyprexa as a result of its illegal marketing, and millions more spent for treatment of serious side effects from Zyprexa.” Lilly is already a defendant in a lawsuit filed by the state of Alaska. The trial in that case, which began last month, has similar accusations involving marketing and side effects associated with Zyprexa, which is by far Lilly’s biggest product. Lilly had sales of Zyprexa of $4.76 billion in 2007, $2.24 billion of which was in the U.S.
Lilly is accused of promoting Zyprexa for unapproved uses, including the treatment of children, and of hiding dangerous side effects, such as increased risk of diabetes, weight gain, and heart problems. Attorney General Blumenthal made this statement when he filed the suit:
Through a complex series of illegal rackets and lies, Eli Lilly built a multibillion-dollar drug enterprise at the expense of taxpayers, consumers and patient lives. Eli Lilly adopted a sick marketing mindset: profits over patients, sales over safety.
The Attorney General accused Lilly of promoting the drug for anxiety, depression, and attention deficit disorder in children despite its not receiving FDA approval for those uses. Although doctors may prescribe medicines in any way they see fit, companies are allowed to promote them only for uses approved by U.S. health regulators. The drug maker was accused of corrupting doctors, pharmacies, and public officials nationwide. Between 1996 and 2006, the Connecticut Medical Assistance Programs spent more than $190 million on Zyprexa, and millions more were spent to treat injuries caused by Zyprexa. The Attorney General has been involved in private negotiations with Lilly over Zyprexa, and a settlement with federal prosecutors may be in the works.
An interesting development occurred during the trial. John C. Lechleiter, an Eli Lilly official who is about to become the company’s top executive, wrote an e-mail message in March 2003 that encouraged Lilly to promote Zyprexa for a use not approved by federal drug regulators. His comments were sent to other Lilly executives after he traveled to Cincinnati to watch Lilly sales representatives talk to doctors. In his e-mail message, Mr. Lechleiter discussed the use of Zyprexa by children and teenagers. Mr. Lechleiter, who was then the company’s executive vice-president for pharmaceutical products, noted to other Lilly officials that company representatives were already promoting Strattera, a second Lilly psychiatric drug, to pediatricians and child psychiatrists. The representatives could also discuss Zyprexa with these doctors. Mr. Lechleiter wrote in his email message:
The fact we are now talking to child psychs and peds and others about Strattera means that we must seize the opportunity to expand our work with Zyprexa in this same child-adolescent population.
Mr. Lechleiter also encouraged Lilly to get data on the use of Zyprexa in treating “disruptive kids” in order to increase the drug’s sales. The trial judge wouldn’t allow the email to be admitted into evidence because off-label use isn’t at issue in the case. This disclosure nonetheless comes at a sensitive moment for Lilly, which is also under federal criminal investigation for the way it promoted Zyprexa and played down the drug’s risks to doctors. Internal Lilly documents show that from 2000 to 2002 the company aggressively tried to expand Zyprexa’s sales into markets for executive on April 1st, succeeding Sidney Taurel, and is to succeed Mr. Taurel as Lilly’s chairman at the end of the year. The trial in Alaska is being watched carefully by other drug companies.
Source: Reuters & New York Times
1 Comment
Leave a Reply
- Favorite Bible verses
- Medical Device Legislation Introduced in Congress
- Pursuing a humble heart
- Favorite Bible verses
- A report on the medical devices legislation
- President Obama calls for new consumer protections
- Joan Claybrook honored in Washington
- Complaint filed against Arkansas nursing home
- Lawsuit filed in Geo Tracker rollover death case
- Richard Scrushy is held to be responsible for Health South fraud
- Exxon ordered to pay $507.5 million for 1989 Alaska oil spill
- Court upholds settlement in asbestos lawsuits
- Supreme Court rules against Massey Unit in judicial bias case
- Recent decisions from the U.S. Supreme Court
- GOP lawmakers warned by ALFA
- Thank you for the beautiful and encouraging Bible verses. Think I will share th...
- This is a very nice article,may the good Lord continue to bless you. Pls I would...
- It was such a pleasure to come across your web site while searching for informat...
- I just want to thank you for all the hard work your firm has done. I'm am so hap...
- As a delegate to the State-wide Mock Constitutional Convention and a member of t...
- Why is no one looking at the actual cost to build the property ? Comparing it to...
- Thank you for your testimony, in an adversarial world. I always enjoy receiving...
- I don't Know about the other cases, but I know that the women who sued Mcdonalds...
- Beasley Allen
- Jere Beasley Report
- Extreme Montgomery
- Coal Ash Spill
- Leaking Storage Tank
- Yamaha Rhino Lawyer
- Mesothelioma Lawyer
- Personal Injury Lawyer
- Nursing Home Abuse
- Mesothelioma Blog
- Morgan Keegan Investment Fraud
- Employee Rights
- Unum Provident Denied Disability
- Paxil and Pregnancy
- Steven Johnson Syndrome (SJS)
- Avandia and Heart Attacks
- Reglan Lawyer
- Digitek Recall
- Kugel Hernia Patch Recall
- Pain Pumps
- Trasylol Recall
- Heparin Recall
- Medtronic Heart Lead Recall
- Vytorin Cancer
- Fleet Attorney
- Chantix Recall
- HRT and Breast Cancer
- Ortho Evra and Blood Clots
- Fosamax and ONJ
- Gadolinium and NSF
Recent Settlements - Jul 1, 2009 7:20 - 0 Comments
Serious eye injury case settled in Pike County
More In Recent Settlements
- Greg Allen settles case with Ford Motor Company
- Settlement of roof crush case
- Settlement of Ford Explorer and Firestone tire case
- Insurance Fraud Settlement Involving Liberty Life Insurance Co.
- ALFA Found Guilty Of Insurance Fraud
Product Liability - Jul 1, 2009 7:19 - 0 Comments
The single vehicle accident: a series highlighting often overlooked product claims
More In Product Liability
- Illinois jury returns $2 million asbestos injury verdict
- Three teens killed and six hurt in SUV rollover
- Our clients are examples of the hardest hit victims of the GM and Chrysler bankruptcies
- IIHS research on child seats is revealing
- NHTSA releases new roof crush standard
Eli Lilly is being sued for fraudulent promotion of it’s Zyprexa drug, by the Attorney Generals of over a dozen states.